Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.

O'Brien, T; Ahn, JS; Chye, R; Le, B; Lu, H; Olarte, G; Palladini, M; Salti, A; Shao, Y-Y; Yaakup, H; Buemio, KC; Colin, CG; Hadjiat, Y

Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.

O'Brien, T Ahn, JS Chye, R Le, B Lu, H Olarte, G Palladini, M Salti, A Shao, Y-Y Yaakup, H Buemio, KC Colin, CG Hadjiat, Y

Permalink

Publisher:: Weston Medical Publishing
Publication Type:: Journal Article
Citation:: J Opioid Manag, 2019, 15, (2), pp. 147-158
Issue Date:: 2019-03

Closed Access

	Filename	Description	Size
	2402-4893-1-SM.pdf	Published version	2.05 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	O'Brien, T
dc.contributor.author	Ahn, JS
dc.contributor.author	Chye, R
dc.contributor.author	Le, B
dc.contributor.author	Lu, H
dc.contributor.author	Olarte, G
dc.contributor.author	Palladini, M
dc.contributor.author	Salti, A
dc.contributor.author	Shao, Y-Y
dc.contributor.author	Yaakup, H
dc.contributor.author	Buemio, KC
dc.contributor.author	Colin, CG
dc.contributor.author	Hadjiat, Y
dc.date.accessioned	2022-09-02T02:35:09Z
dc.date.available	2022-09-02T02:35:09Z
dc.date.issued	2019-03
dc.identifier.citation	J Opioid Manag, 2019, 15, (2), pp. 147-158
dc.identifier.issn	1551-7489
dc.identifier.issn	2375-0146
dc.identifier.uri	http://hdl.handle.net/10453/161206
dc.description.abstract	Transdermal buprenorphine (TDB) has demonstrated effectiveness in treating a range of chronic pain conditions, including cancer pain, nociceptive pain, and neuropathic pain and has a favorable safety profile. Worldwide, clinical experience of its use is relatively limited. There is considerable misunderstanding about the pharmacology, mechanism of action, and safety of buprenorphine. There is also limited guidance on the appropriate use of TDB for chronic pain management. This article presents an overview of TDB and also provides practical recommendations for its use as part of a multifaceted strategy in chronic cancer and non-cancer pain.
dc.format	Print
dc.language	eng
dc.publisher	Weston Medical Publishing
dc.relation.ispartof	J Opioid Manag
dc.relation.isbasedon	10.5055/jom.2019.0496
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1117 Public Health and Health Services, 1702 Cognitive Sciences
dc.subject.classification	Anesthesiology
dc.subject.mesh	Analgesics, Opioid
dc.subject.mesh	Buprenorphine
dc.subject.mesh	Chronic Pain
dc.subject.mesh	Humans
dc.subject.mesh	Neoplasms
dc.subject.mesh	Pain Management
dc.subject.mesh	Pain Measurement
dc.subject.mesh	Transdermal Patch
dc.subject.mesh	Humans
dc.subject.mesh	Neoplasms
dc.subject.mesh	Buprenorphine
dc.subject.mesh	Analgesics, Opioid
dc.subject.mesh	Pain Measurement
dc.subject.mesh	Transdermal Patch
dc.subject.mesh	Pain Management
dc.subject.mesh	Chronic Pain
dc.title	Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.
dc.type	Journal Article
utslib.citation.volume	15
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
utslib.for	1117 Public Health and Health Services
utslib.for	1702 Cognitive Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2022-09-02T02:34:44Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	15
utslib.citation.issue	2

Abstract:

Transdermal buprenorphine (TDB) has demonstrated effectiveness in treating a range of chronic pain conditions, including cancer pain, nociceptive pain, and neuropathic pain and has a favorable safety profile. Worldwide, clinical experience of its use is relatively limited. There is considerable misunderstanding about the pharmacology, mechanism of action, and safety of buprenorphine. There is also limited guidance on the appropriate use of TDB for chronic pain management. This article presents an overview of TDB and also provides practical recommendations for its use as part of a multifaceted strategy in chronic cancer and non-cancer pain.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/161206